首页> 外国专利> Composition for inhibiting a growth of lung cancer stem cells comprising ciclesonide

Composition for inhibiting a growth of lung cancer stem cells comprising ciclesonide

机译:用于抑制肺癌干细胞生长的组合物,其包含环索奈德

摘要

The present invention comprises a ciclesonide or a pharmaceutically salt thereof as an active ingredient, a composition for inhibiting cancer stem cell growth, inhibiting metastasis of cancer comprising the composition, or a pharmaceutical composition for treating or preventing cancer, a food composition Etc. The ciclesonide of the present invention inhibits the growth of breast cancer and lung cancer cells, and inhibits the formation of breast cancer and lung cancer stem cells. In addition, it inhibited the expression of self-renewing genes such as Nanog, C-myc, Oct4, Sox2, Snail and CD44, which are known to be characteristically expressed in breast and lung cancer stem cells. Inhibition of the production of IL-6 and IL-8, which are known to be involved in the formation of tumor pairs, was confirmed to inhibit the STAT3 signaling pathway. Accordingly, the compound inhibits the growth of cancer stem cells, such as breast cancer and lung cancer, and the growth of these cancers, and can be used for the treatment of cancers such as breast cancer and lung cancer.
机译:本发明包括作为活性成分的环索奈德或其药学上的盐,用于抑制癌症干细胞生长,抑制癌症转移的组合物,或用于治疗或预防癌症的药物组合物,食品组合物等。本发明的“抑癌作用”抑制乳腺癌和肺癌细胞的生长,并抑制乳腺癌和肺癌干细胞的形成。此外,它抑制了自我更新基因的表达,例如Nanog,C-myc,Oct4,Sox2,Snail和CD44,这些基因已知在乳腺癌和肺癌干细胞中具有特征性表达。已证实抑制已知参与肿瘤对形成的IL-6和IL-8的产生可抑制STAT3信号通路。因此,该化合物抑制诸如乳腺癌和肺癌的癌症干细胞的生长以及这些癌症的生长,并且可以用于治疗诸如乳腺癌和肺癌的癌症。

著录项

  • 公开/公告号KR102039298B1

    专利类型

  • 公开/公告日2019-10-31

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20190116815

  • 发明设计人 이동선;최학선;

    申请日2019-09-23

  • 分类号A61K31/58;A23L33/10;A61K31/573;

  • 国家 KR

  • 入库时间 2022-08-21 11:47:25

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号